Deborah L Tanner Insider Trading $WST WEST PHARMACEUTICAL SERVICES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Deborah L Tanner.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Deborah L Tanner. Deborah L Tanner is CEO, Covance Drug Development in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and in WEST PHARMACEUTICAL SERVICES INC ($WST) and Corp. Executive Vice President in COVANCE INC ($CVD) and Corporate Sr. Vice President in COVANCE INC ($CVD).
Deborah L Tanner in WEST PHARMACEUTICAL SERVICES INC
Industry: FABRICATED RUBBER PRODUCTS, NEC [3060]
Position of Deborah L Tanner:
Holdings: 7,774 shares
Current Value: $665,921
Latest Transaction: May 06 2021
$WST Market Capitalization: $6.29B
$WST Previous Close: $85.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Deborah L Tanner in WEST PHARMACEUTICAL SERVICES INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2021 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Grant | A | 0.00 | 577 | 0 | 7,774 | 7.2 K to 7.8 K (+8.02 %) | |
| May 07 2020 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Grant | A | 0.00 | 975 | 0 | 7,180 | 6.2 K to 7.2 K (+15.71 %) | |
| May 09 2019 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Grant | A | 0.00 | 1,565 | 0 | 4,881 | 3.3 K to 4.9 K (+47.20 %) | |
| Oct 02 2018 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Option Exercise | A | 0.00 | 162 | 0 | 1,072 | ||
| Aug 01 2018 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Option Exercise | A | 0.00 | 202 | 0 | 910 | ||
| Aug 01 2018 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Option Exercise | A | 0.00 | 228 | 0 | 708 | ||
| Aug 01 2018 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Option Exercise | A | 0.00 | 202 | 0 | 480 | ||
| May 03 2018 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Grant | A | 0.00 | 1,824 | 0 | 3,309 | 1.5 K to 3.3 K (+122.83 %) | |
| Oct 03 2017 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Option Exercise | A | 0.00 | 208 | 0 | 278 | ||
| Jul 05 2017 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Option Exercise | A | 0.00 | 71 | 0 | 71 | ||
| Jun 02 2017 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Grant | A | 0.00 | 1,483 | 0 | 1,483 | 0 to 1.5 K |
Page: 1